With 1.92 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.26 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $2.8599 whereas the lowest price it dropped to was $2.25. The 52-week range on LUCY shows that it touched its highest point at $27.20 and its lowest point at $1.70 during that stretch. It currently has a 1-year price target of $9.00. Beta for the stock currently stands at 1.80.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LUCY was up-trending over the past week, with a rise of 18.69%, but this was down by -38.64% over a month. Three-month performance dropped to -58.19% while six-month performance fell -68.62%. The stock lost -54.81% in the past year, while it has lost -52.24% so far this year. A look at the trailing 12-month EPS for LUCY yields -6.77 with Next year EPS estimates of 0.69.
Float and Shares Shorts:
At present, 2.45 million LUCY shares are outstanding with a float of 1.19 million shares on hand for trading. On 2025-03-31, short shares totaled 44058.0, which was 179.99999999999997 higher than short shares on 1740700800. In addition to Mr. Harrison Reed Gross as the firm’s Co-Founder, CEO & Director, Mr. Konrad Dabrowski serves as its Co-CFO & Co-Founder.
Institutional Ownership:
Through their ownership of 0.00877 of LUCY’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-12-31, LUCY reported revenue of $690688.0 and operating income of -$2172690.0. The EBITDA in the recently reported quarter was -$2085848.0 and diluted EPS was $nan.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With LUCY analysts setting a high price target of 9.0 and a low target of 9.0, the average target price over the next 12 months is 9.0. Based on these targets, LUCY could surge 282.98% to reach the target high and rise by 282.98% to reach the target low. Reaching the average price target will result in a growth of 282.98% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$5.19 being high and -$5.19 being low. For LUCY, this leads to a yearly average estimate of -$5.19. Based on analyst estimates, the high estimate for the next quarter is -$0.69 and the low estimate is -$0.69. The average estimate for the next quarter is thus -$0.69.
